SCHEMBL3249160

SCHEMBL3249160

O=C(CNS(=O)(=O)c1ccccc1)Nc1ccc(Cl)cc1Cc1ccccc1Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.53
MAPT P10636 3/20 0.53
LMNA P02545 2/20 0.53
HTT P42858 2/20 0.53
TSHR P16473 1/20 0.49
ERBB2 P04626 1/20 0.46
HSP90AA1 P07900 1/20 0.46
HSP90AB1 P08238 1/20 0.46
FLT1 P17948 1/20 0.44
FLT4 P35916 1/20 0.44
KDR P35968 1/20 0.44
MEN1 O00255 1/20 0.44
POLB P06746 1/20 0.44
KMT2A Q03164 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C19 P33261 1/20 0.44
MEP1B Q16820 1/20 0.43
HDAC8 Q9BY41 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3253246 0.96 MEP1B (0.48) ALDH1A1MAPTLMNAHTTTSHR
SCHEMBL3255473 0.90 ALDH1A1 (0.47) ALDH1A1MAPTLMNAHTTTSHR
SCHEMBL3247111 0.90 FLT1 (0.48) ALDH1A1MAPTLMNAHTTTSHR
SCHEMBL3251190 0.89 ALDH1A1 (0.46) ALDH1A1MAPTLMNAHTTTSHR
SCHEMBL3253721 0.89 TSHR (0.48) ALDH1A1MAPTTSHRERBB2FLT1
SCHEMBL4869124 0.89 GAA (0.44) ALDH1A1MAPTLMNAHTTTSHR
SCHEMBL3256141 0.89 PTGES (0.47) ALDH1A1MAPTLMNAHTTTSHR
SCHEMBL4860809 0.88 L3MBTL1 (0.46) ALDH1A1MAPTLMNAHTTMEN1
SCHEMBL3255565 0.87 MEP1B (0.55) ALDH1A1MAPTLMNAHTTTSHR
SCHEMBL3252246 0.87 ALDH1A1 (0.62) ALDH1A1MAPTLMNAHTTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1776347-B1 SULPHONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI AVENTIS (FR) 2010-05-26 EP disclosed
US-7396958-B2 Sulphonamide derivatives, their preparation and their therapeutic application SANOFI AVENTIS (FR) 2008-07-08 US disclosed
US-20070185136-A1 SULPHONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION SANOFI-AVENTIS (FR) 2007-08-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070185136-A1 SULPHONAMIDE DERIVATIVES, THEIR PREPARATION AND THEIR THERAPEUTIC APPLICATION HCRTR2, GIPR, SSTR2 ALDH1A1 2179/4885MAPT 3113/4885LMNA 3046/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.